The prognostic value of inducible nitric oxide synthase in local prostate cancer

BJU International

Volumn 86, Issue 3, 2000, Pages 234-239

  Aaltomaa, S H ^a   Lipponen, P K ^b   Viitanen, J ^c   Kankkunen, J P ^a   Ala Opas, M Y ^d   Kosma, V M ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Joensuu Central Hospital   (Finland)

^d NONE

Author keywords

Grade; Inducible nitric oxide synthase; Prognosis; Prostate cancer; Stage

Indexed keywords

NITRIC OXIDE SYNTHASE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; ENZYME INDUCTION; FINLAND; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; SEMINAL VESICLE DISEASE; TUMOR CLASSIFICATION;

DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0033862814     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00787.x     Document Type: Article

References (26)

1. 1 ES-Japan Cooperative Cancer Research Program. Seminar of nitric oxide synthase and carcinogenesis. Cancer Res 1994; 54: 297-301
2. 2 Schmidt HHHW, Walter U. NO at work. Cell 1994; 78: 919-25
3. 3 Hibbs JB Jr, Taintor RR, Vavrin Z et al. Synthesis of nitric oxide from terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In Moncada S. Higgs EA, eds, Nitric Oxide from l-argine: A Bioregulatory System. Proceedings of Symposium on Biological Importance of Nitric Oxide. Amsterdam: Elsevier, 1990: 189-223
4. 4 Doi K, Akaike T, Horie H et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 1996; 77: 1598-604
5. 5 Kojima M. Morisaki T, Tsukahara Y et al. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 1999; 70: 222-9
6. 6 Kitano H, Kitanishi T, Nakanishi Y et al. Expression of inducible nitric oxide synthase in human thyroid papillary carcinomas. Thyroid 1999; 9: 113-7
7. 7 Swana US, Smith SD, Perrotta PL. Saito N. Wheeler MA, Weiss RM. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol 1999; 161: 630-4
8. 8 Tschugguel W, Pustelnik T, Lass H et al. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer 1999; 79: 1609-12
9. 9 Tanaka H, Kijima H. Tokunaga T et al. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int J Oncol 1999; 14: 1069-73
10. 10 Klotz T. Bloch W. Volberg C, Engelmann U, Addics K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998; 82: 1897-903
11. 11 Aaltomaa S, Lipponen P, Kosma V-M. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. submitted 1999;
12. 12 International Union Against Cancer (UICC). TNM classification of malignant tumours. Geneva: UICC, 1992
13. 13 Vesalainen S, Lipponen P, Talja M, Syrjänen K. Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate 1995; 26: 80-6
14. 14 Feneley MR, Gillait DA, Hehir M, Kirby RS. A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome. Br J Urol 1996; 78: 911-8
15. 15 Cookson MS, Fleshner NE, Soloway SM, Fair WR. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 1997; 157: 559-62
16. 16 Klotz T, Bloch W, Jacobs G, Niggemann S, Engelmann U, Addics K. Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology 1999; 54: 416-9
17. 17 Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994; 54: 1352-4
18. 18 Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 1998; 17: 107-18
19. 19 Jenkins DC, Charles IG, Baylis SA, Lelchuk R. Radomski MV, Moncada S. Human colon cancer cell lines show diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 1994; 70: 847-9
20. 20 Ropponen KM. Expression of iNOS (inducible nitric oxide synthase) in colorectal cancer and its association with prognosis. Scand J Gastroenterol 2000; in press.
21. 21 Jansson OT, Marcos E, Brundin L, Bergerheim USR, Adolfsson J, Wiklund NP. Nitric oxide synthase activity in human renal cell carcinoma. J Urol 1998; 160: 556-60
22. 22 Brewster SF, Oxley JD, Trivella M, Abbott CD, Gleason DF. Preoperative p53. bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy. J Urol 1999; 161: 1238-43
23. 23 Noordzij MA, Steenbrugge GJ, Verkaik NS, Schroder FH, van der Kwast TH. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin Cancer Res 1997: 3: 805-15
24. 24 Vesalainen S, Lipponen P, Talja M, Syrjänen K. Histological grade, perineural infiltration, tumor-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994; 30A: 1797-803
25. 25 Stamey TA. Donaldson AN, Yemoto CE, McNeal JE, Sözen S, Gill H. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostalectomy: epidcmiologic significance of annual changes. J Urol 1998; 160: 2412-7
26. 26 D'amico AV, Whittington R, Malkowicz S et al. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 1998; 160: 2096-101